Medical Journals

Antimutagenicity of Ursolic Acid and Oleanolic Acid Against Doxorubicin-induced Clastogenesis in Balb/C Mice.

Authors:
  • Aparecida Resende Flávia
  • de Andrade Barcala Claudete Aparecida Mattos
  • da Silva Faria Márcia Cristina
  • Kato Fabiana Hibary
  • Cunha Wilson Roberto
  • Tavares Denise Crispim

From: Universidade de Franca, Avenida Dr. Armando Salles de Oliveira, 201-Parque Universitário, 14404-600, Franca, São Paulo, Brazil.

Life sciences

  • Publish Date: Aug 2006
  • ISSN: 0024-3205
  • Volume: 79
  • Issue: 13
  • Pages: 1268-73
  • Medium: Print
  • Language: English
  • Citation (JAMA): Aparecida Resende Flávia, de Andrade Barcala Claudete Aparecida Mattos, da Silva Faria Márcia Cristina, et al. Antimutagenicity of Ursolic Acid and Oleanolic Acid Against Doxorubicin-induced Clastogenesis in Balb/C Mice.. Life Sci. Aug 2006;79:1268-73

Abstract

Ursolic acid (UA) and oleanolic acid (OA) are triterpenoid compounds found in food, medicinal herbs and various other plants in free form or bound to glycosides. Both substances are known for their antimicrobial, hepatoprotective, anti-inflammatory, antiallergic, antiviral and cytotoxic activities. In the present study, we evaluated the antimutagenic potential of UA and OA using the micronucleus test in peripheral blood and bone marrow of Balb/c mice. The animals were divided into 10 treatment groups: mice treated with UA (80 mg/kg b.w.); OA (80 mg/kg b.w.); a mixture of UA and OA (80 mg/kg b.w.); the antineoplastic agent doxorubicin (DXR, 90 mg/kg b.w.); DMSO and DXR; UA and DXR; OA and DXR; UA, OA and DXR, and negative and solvent controls. UA, OA and a mixture of UA and OA were administered to the animals by gavage, followed by the intraperitoneal injection of DXR. The results showed a significant reduction in micronucleus frequency in the groups concomitantly treated with the triterpenoid compounds and DXR compared to that treated with DXR alone. The present results demonstrate the antimutagenic activity of UA and OA under the experimental conditions used in this study.

Mesh Headings (Keywords): Animals, Antimutagenic Agents, Antineoplastic Agents, Phytogenic, Bone Marrow Cells, Doxorubicin, Erythrocytes, Mice, Mice, Inbred BALB C, Micronucleus Tests, Mutagens, Oleanolic Acid, Triterpenes


Check for Full Text / PubMed Unique Identifier (PMID): 16647723


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.